CLINIPRIME Trademark

Trademark Overview


On Wednesday, August 3, 2022, a trademark application was filed for CLINIPRIME with the United States Patent and Trademark Office. The USPTO has given the CLINIPRIME trademark a serial number of 97533508. The federal status of this trademark filing is REGISTERED as of Tuesday, January 9, 2024. This trademark is owned by Charles River Laboratories, Inc.. The CLINIPRIME trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Cells for medical or clinical use; Solutions for medical and clinical use in storing and treating cells, blood and blood components; Stem cells for medical or veterinary use; Stem cells for medical purposes

Biological tissue, namely, bone marrow, cord blood, normal peripheral blood, and mobilized peripheral blood, for use in scientific and medical research; Cells for scientific and research use; Cells for scientific, laboratory or medical research; Stem cells for research purposes; Biological tissue, namely, blood, stem cells, umbilical cords and placentas for scientific and medical research use; Stem cells for research or scientific purposes; Biological tissue, namely, blood for scientific or medical research use
cliniprime

General Information


Serial Number97533508
Word MarkCLINIPRIME
Filing DateWednesday, August 3, 2022
Status700 - REGISTERED
Status DateTuesday, January 9, 2024
Registration Number7271459
Registration DateTuesday, January 9, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 1, 2022

Trademark Statements


Goods and ServicesCells for medical or clinical use; Solutions for medical and clinical use in storing and treating cells, blood and blood components; Stem cells for medical or veterinary use; Stem cells for medical purposes
Pseudo MarkCLINICAL PRIME
Goods and ServicesBiological tissue, namely, bone marrow, cord blood, normal peripheral blood, and mobilized peripheral blood, for use in scientific and medical research; Cells for scientific and research use; Cells for scientific, laboratory or medical research; Stem cells for research purposes; Biological tissue, namely, blood, stem cells, umbilical cords and placentas for scientific and medical research use; Stem cells for research or scientific purposes; Biological tissue, namely, blood for scientific or medical research use

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateSaturday, September 24, 2022
Primary Code001
First Use Anywhere DateMonday, January 16, 2023
First Use In Commerce DateMonday, January 16, 2023

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 25, 2022
Primary Code005
First Use Anywhere DateMonday, January 16, 2023
First Use In Commerce DateMonday, January 16, 2023

Trademark Owner History


Party NameCharles River Laboratories, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWilmington, MA 01887

Party NameCharles River Laboratories, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWilmington, MA 01887

Party NameCharles River Laboratories, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWilmington, MA 01887

Trademark Events


Event DateEvent Description
Tuesday, January 9, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 9, 2024REGISTERED-PRINCIPAL REGISTER
Wednesday, December 6, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 5, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, November 10, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 10, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, August 12, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, August 12, 2023NON-FINAL ACTION E-MAILED
Saturday, August 12, 2023SU - NON-FINAL ACTION - WRITTEN
Tuesday, May 23, 2023DIVISIONAL REQUEST RECEIVED
Wednesday, July 12, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 14, 2023USE AMENDMENT FILED
Wednesday, July 12, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 14, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, December 27, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 1, 2022PUBLISHED FOR OPPOSITION
Wednesday, October 12, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 26, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, September 24, 2022EXAMINER'S AMENDMENT ENTERED
Saturday, September 24, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, September 24, 2022EXAMINERS AMENDMENT E-MAILED
Saturday, September 24, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, September 23, 2022ASSIGNED TO EXAMINER
Thursday, August 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 6, 2022NEW APPLICATION ENTERED